Stroke, Vol 15, 241-243, Copyright © 1984 by American Heart Association
G Boysen, AH Boss, N Odum and JS Olsen
Platelet aggregation and bleeding time was measured in 43 cerebrovascular
patients participating in a controlled double-blind study of low-dose
acetylsalicylic acid. In 19 patients with satisfactory inhibition of the
platelet aggregation obtained by 50 to 70 mg acetylsalicylic acid per day
the bleeding time averaged 11.2 minutes in contrast to 7.0 minutes in the
placebo group, p less than 0.001. This study confirms our previous findings
of platelet inhibition by low-dose acetylsalicylic acid in patients with
cerebrovascular disease. The prolongation of the bleeding time demonstrates
that we are dealing not merely with an in vitro phenomenon but with a
significant in vivo effect. The study provides the rationale for clinical
evaluations of low-dose acetylsalicylic acid in stroke prophylaxis.
ARTICLES
Prolongation of bleeding time and inhibition of platelet aggregation by low-dose acetylsalicylic acid in patients with cerebrovascular disease
This article has been cited by other articles:
![]() |
J.M Cruz-Fernandez, L Lopez-Bescos, D Garcia-Dorado, V Lopez Garcia-Aranda, A Cabades, L Martin-Jadraque, J.A Velasco, A Castro-Beiras, F Torres, F Marfil, et al. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction Eur. Heart J., March 2, 2000; 21(6): 457 - 465. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |